Million Veterans Database Used in Large-Scale Analysis for Cardiometabolic Traits

Noting that studies linking mitochondrial DNA (mtDNA) with complex traits are often limited by small sample sizes or focused on specific phenotypes in clinically selected cohorts, researchers recently reported data from more than 600,000 participants in the Million Veteran Program (MVP) to perform a multiancestry analysis of mitochondrial DNA (mtDNA) variation and cardiometabolic phenotypes across European (EUR), African (AFR), Admixed American (AMR) and East Asian (EAS) populations.

COVID-19 Vaccine Shows Significant Protection Against MACE in Veterans 75 or Older

Past research has demonstrated that receipt of vaccines was associated with reduced COVID-19–associated cardiovascular risk. A new study took that a step further, finding evidence of vaccine effectiveness against the broader outcome—all-cause major adverse cardiovascular events (MACEs), suggesting that “likely reflects the hidden burden of undetected SARS-CoV-2 and associated complications that are amenable to reduction by COVID-19 vaccination.”

For Veterans With Familial Hypercholesterolemia, More Treatment Options Now Available

VA research is helping to change the massive underdiagnosis and undertreatment of familial hypercholesterolemia (FH), using the unparalleled scale of the Million Veteran Program to identify affected veterans and return actionable results. As the treatment landscape expands, including multiple PCSK9 inhibitor option, clinicians now have the tools to bring even severely elevated LDL-C under control.

Ibrutinib Linked to Increased Risk of Sudden Cardiac Death, Asymptomatic Arrhythmias

Ibrutinib, a Bruton’s tyrosine kinase inhibitor (BTKi) widely used in the treatment of chronic lymphocytic leukemia (CLL) and other hematologic malignancies, continues to demonstrate cardiovascular risks beyond the well-known complications of hypertension and atrial fibrillation, according to new data from researchers at the National Institutes of Health and Uniformed Services University of the Health Sciences.

ECG-Based Devices Should Be Used to Evaluate Heart Rate Variability in Adults

In adults, pulse rate variability (PRV) and heart rate variability (HRV) aren’t interchangeable, and electrocardiography (ECG)-based devices should be used when HRV is clinically relevant and autonomic function needs to be evaluated, according to a study that addressed misinformation on wearable smart devices purchased by consumers to monitor their health.

Mary Jo Pugh Spearheads Research Into TBI Link to Heart Issues

As an investigator at the Informatics, Decision-Enhancement and Analytic Sciences Center of Innovation (IDEAS COIN) at the Salt Lake City VA, the longitudinal studies that Mary Jo Pugh, PhD, RN, has helped build during her 25-year career have demonstrated that traumatic brain injury (TBI) greatly increases a patient’s risk for a host of comorbidities, most notably chronic cardiovascular disease.